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Abstract 
RNA interference (RNAi) is a homology-based and antisense small RNA-dependent gene 
silencing mechanism found in most eukaryotes. This dissertation describes identification and 
characterization of three novel RNAi pathway components in nematode Caenorhabditis elegans: 
rde-10, rde-11 and rde-12. We demonstrated that they are required for targeted mRNA 
degradation and the subsequent secondary siRNA biogenesis. 
The molecular mechanisms for targeted mRNA degradation in C. elegans undergoing 
RNA interference (RNAi) are not fully understood.  Using a combination of genetic, proteomic 
and biochemical approaches, we have identified a divergent RDE-10/RDE-11 complex that is 
required for RNAi in C. elegans. Genetic analysis indicates that the RDE-10/RDE-11 complex 
acts in parallel to nuclear RNAi.  Association of the complex with target mRNA is dependent on 
RDE-1 but not RRF-1, suggesting that target mRNA recognition depends on primary but not 
secondary short interfering RNA (siRNA).  Furthermore, RDE-11 is required for mRNA 
degradation subsequent to target engagement. Results of deep sequencing analyses reveal a 5-
fold decrease in secondary siRNA abundance in rde-10 and rde-11 mutant animals, despite 
normal primary siRNA and micro-RNA biogenesis. Therefore, the RDE-10/RDE-11 complex is 
critical for amplifying the exogenous RNAi response. Our work uncovers an essential output of 
the RNAi pathway in C. elegans. 
RDE-12, a putative DEAD-box RNA helicase, was identified from the same genetic 
screen. A GFP::RDE-12 fusion protein forms cytoplasmic foci in somatic cells and resides in 
peri-nuclear P granules in the germline. RDE-12 engages target mRNAs in response to RNAi 
and is required for the secondary siRNA biogenesis. We hypothesize that RDE-12 acts as a 
linkage between mRNA targeting and secondary siRNA synthesis in the RNAi pathway.      
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Chapter 1 
 
General introduction 
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Overview of RNA interference 
Before the discovery of RNA interference, the antisense RNA technique was used to 
inhibit gene expression in a sequence-specific manner (Izant and Weintraub 1984; Fire et 
al. 1991). Due to inconsistency and marginal efficacy, this technique was considered 
unreliable. Especially, researchers found that sense RNA could also inhibit gene 
expression (Guo and Kemphues 1995). Later, researchers found that double stranded 
RNA (dsRNA), the byproduct of antisense RNA preparations, was the trigger of this 
dsRNA-mediated interference (Fire et al. 1998), which was eventually named RNA 
interference (RNAi). RNAi has been widely utilized at every aspect of biomedical 
research since it is capable of facilitating genetic analysis without genetic mutants. RNAi 
in C elegans can be easily induced by feeding bacteria that express dsRNA. The 
convenience of genetic manipulation and laboratory husbandry of C. elegans makes it an 
ideal model organism for studying the basic mechanism of RNAi. 
Double-stranded RNA (dsRNA), when introduced into cells of eukaryotes, can 
cause degradation of mRNAs that contain sequences homologous to the trigger dsRNA. 
Eukaryotes employ proteins similar to those in worms, such as Dicer and Argonaute, to 
achieve gene silencing. The process of RNAi can generally be divided into three steps: 
dsRNA cleavage, RNA Induced Silencing Complex (RISC) assembly, and target mRNAs 
silencing (Fig 1.1) (Hammond et al. 2000; Elbashir et al. 2001; Ketting et al. 2001; 
Knight and Bass 2001). dsRNA is cleaved by RNase III Dicer-like protein into 21-25 
nucleotide RNA duplexes (Elbashir et al. 2001; Ketting et al. 2001; Knight and Bass 
2001). One strand of the duplex, termed siRNA, is selectively loaded into RISC 
(Martinez et al. 2002; Khvorova et al. 2003; Schwarz et al. 2003; Tomari et al. 2004). 
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RISC is the effector complex for gene silencing. Argonaute Family proteins, the key 
components of RISCs, directly bind siRNAs to recognize the target and to mediate gene 
silencing at transcriptional and post-transcriptional level (Tabara et al. 1999; Hammond 
et al. 2001; Liu et al. 2004; Batista et al. 2008; Guang et al. 2008; Claycomb et al. 2009; 
Gu et al. 2009; Buckley et al. 2012). One of the current major caveats in RNAi-based 
gene therapy is that essential small RNA regulatory pathways are impaired after 
introducing siRNA(Grimm et al. 2006). Therefore, further understanding about how 
distinct silencing mechanisms are employed by divergent RNAi pathway components 
will provide insights for RNAi-based gene therapy.  
 
Dicer dices dsRNA 
Dicer proteins act at the initial phase of RNAi to cut dsRNA into ~21-25 nt small RNA 
duplex (Bernstein et al. 2001; Ketting et al. 2001; Knight and Bass 2001). The Dicer 
family is evolutionarily conserved in worms, flies, plants, fungi and mammals. Humans 
and C. elegans only have one dicer which is shared between the siRNA pathway and the 
miRNA pathway. Dicer proteins possess a helicase domain, two RNase III motifs and 
one PAZ domain. The two RNase III domains coordinate to cut dsRNAs (Weinberg et al. 
2011), which makes Dicer as a molecular ruler to cut dsRNA into exact 21-25 nt small 
RNA duplex in different organisms. PAZ domain, also observed in Argonaute proteins, 
has been shown to recognize dsRNA ends and specify siRNA length (Zhang et al. 2004; 
MacRae et al. 2007). In flies, R2D2 (the homolog of RDE-4 in C. elegans) bridges the 
initial step and the effector step of RNAi pathway by facilitating siRNA handover from 
Dicer to Argonaute proteins (Fig 1.1) (Liu et al. 2003; Tomari et al. 2004). This handover 
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process is also facilitated by heat shock protein chaperone machinery (Iwasaki et al. 2010; 
Miyoshi et al. 2010) 
 
Distinct Argonautes for multiple silencing mechanisms 
Argonaute proteins act in distinct pathways, such as developmental regulation (miRNA 
pathway) (Fig 1.2) (Grishok et al. 2001), genome integrity (Fig 1.3) (Batista et al. 2008; 
Gu et al. 2012), chromosome segregation (Fig 1.4) (Claycomb et al. 2009), exo-RNAi 
(Fig 1.1) (Tabara et al. 1999; Yigit et al. 2006; Guang et al. 2008; Buckley et al. 2012), 
and the newly defined endo-RNAi (Fig 1.4) (Gu et al. 2009; Conine et al. 2010; Vasale et 
al. 2010) . The C. elegans RDE-1 (RDE: RNAi defective) is the first Argonaute protein 
identified from the study of RNAi defective mutants. Later, mouse Ago2 (Hammond et al. 
2001; Liu et al. 2004), an ortholog of RDE-1, was also shown to be essential for RNAi. 
Argonaute proteins dedicated to the RNAi pathway contain two conserved domains, PAZ 
and PIWI. Structural analyses show that PAZ domain holds the 3’ end of siRNA (Song et 
al. 2004) while the MID-PIWI interface provides the binding pocket for the 5’ end of 
siRNA (Boland et al. 2011). The PIWI domain in Argonaute proteins has a tertiary 
structure similar to that of RNase H. Several Argonaute proteins have been shown to slice 
target mRNAs in the middle of the siRNA binding site via RNase H-like activity in vivo 
and in vitro (Hammond et al. 2001; Liu et al. 2004; Meister et al. 2004; Aoki et al. 2007).  
The C. elegans genome is predicted to encode 23 functional Argonaute proteins. 
Those dedicated to RNAi pathway can be divided into two groups, the primary 
Argonaute (RDE-1) and the secondary Argonautes (Fig 1.1) (Yigit et al. 2006). These 
secondary Argonautes, also known as worm-specific Argonautes (WAGO), are results of 
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unique Argonaute protein family expansion in nematode. RDE-1 binds primary siRNA 
that is directly generated from dsRNA trigger. RRF-1, an RNA dependent RNA 
polymerase, then can use the target mRNA as the template to synthesize antisense siRNA 
(Fig 1.1) (Sijen et al. 2001; Sijen et al. 2007). The siRNA generated through 
amplification by RRF-1 is called secondary siRNA and is loaded into WAGOs. WAGO 
loss of function mutants (Yigit et al. 2006), similar to the primary Argonaute mutant rde-
1, confer an RNAi defective phenotype, which suggests that these WAGOs play an 
important role in RNAi (Fig 1.1). Surprisingly, WAGOs lack the key catalytic residues of 
RNase H which are required for the slicing activity (Yigit et al. 2006). Therefore, 
WAGOs are expected to cooperate with additional factors to mediate target mRNA 
turnover. One WAGO that was defined very recently is NRDE-3 (NRDE: Nuclear RNAi 
DEfective) (Guang et al. 2008). NRDE-3, together with NRDE-2 (a novel protein 
containing a conserved domain of unknown function 1740) (Guang et al. 2010), mediates 
targeted gene silencing by inhibiting transcription elongation. It is still unknown how 
other WAGOs mediate gene silencing, which may potentially be achieved through 
translational repression or target mRNA degradation.  
 The endogenous RNAi pathway employs naturally generated endogenous siRNA 
to regulate gene expression without the introduction of exogenous dsRNA triggers. In C. 
elegans, based on the length and 5’ nucleotide of the endo-siRNAs and their interacting 
Argonaute proteins, endo-siRNA pathways are classified into ERGO-1 26G, ALG-3/4 
26G, and CSR-1 22G pathways (Fig 1.4) (Claycomb et al. 2009; Gu et al. 2009; Han et 
al. 2009; Conine et al. 2010; Vasale et al. 2010). These pathways regulate genome 
integrity at both transcriptional and posttranscriptional level. Several components of exo-
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RNAi have been shown to be required for the accumulation of a subpopulation of endo-
siRNAs (Lee et al. 2006; Gent et al. 2010; Zhang et al. 2011). It is still not clear how 
these components of exo-RNAi pathway participate in the synthesis of some endo-
siRNAs but not the others. 
 ERGO-1 26G small RNAs are endo-siRNAs enriched in oocytes and early 
embryos of C. elegans (Fig 1.4) (Han et al. 2009; Vasale et al. 2010). The molecular 
mechanism of ERGO-1 26G biogenesis is not clear, although several molecular 
requirements have been identified (Han et al. 2009; Vasale et al. 2010). Abolishment of 
the ERGO-1 pathway cause enhanced exo-RNAi effect and reduced brood size under 
high temperature in C. elegans (Han et al. 2009; Pavelec et al. 2009; Vasale et al. 2010). 
The function of ERGO-1 26G pathway is not clear, however, the targets of ERGO-1 26G 
RNA are not random and appear to undergo recent gene duplications.  
 ALG-3/4 26G small RNAs are endo-siRNAs enriched in sperms and targeting 
spermatogensis-enriched mRNAs which are eventually down-regulated by ALG-3/4 26G 
RNAs (Fig 1.4) (Conine et al. 2010). ALG-3/4 localizes to P granules which are 
considered to be a major site of posttranscriptional regulation in germline (Conine et al. 
2010).  
 Both ERGO-1 26G and ALG-3/4 26G RNAs are Dicer-dependent primary 
siRNAs. Similar to primary siRNAs in the exo-RNAi pathway, primary endo-siRNAs 
can initiate secondary siRNAs synthesis. These secondary siRNAs, called WAGO 22G 
RNAs, are bound by a redundant set of worm specific Argonaute proteins (Fig 1.4) (Yigit 
et al. 2006; Gu et al. 2009; Vasale et al. 2010). The secondary siRNAs in both the exo-
RNAi and the endo-RNAi pathways have strong propensity for a 5’ Guanosine (5’ G) 
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residue (Gu et al. 2009; Yang et al. 2012). It is still not clear what the molecular 
mechanism is, presumably because of the higher affinity between GC base pair than AT 
base pair. The WAGO 22G-RNA system silences transposons, pseudogenes, cryptic loci, 
as well as about 50% coding genes (Gu et al. 2009; Zhang et al. 2011). It is conceivable 
that almost every aspect of physiological functions is under the control of WAGO 22G. 
The external signal for the regulation of WAGO 22G RNAs system on gene expression is 
not clear either, although elevated temperature changes the pattern of WAGO 22G 
RNA(Vasale et al. 2010). It has been hypothesized that the WAGO 22G system confers 
the physiological robustness of animals to the variable environment (Gu et al. 2009).  
 
RNA-dependent RNA polymerases (RdRPs) 
In fungi, plants and C. elegans, RNA-dependent RNA polymerases (RdPPs) play an 
essential role in RNA mediated gene silencing. (Cogoni and Macino 1997; Mourrain et al. 
2000; Catalanotto et al. 2002; Pak and Fire 2007; Sijen et al. 2007; Lee et al. 2010). In 
fungi and plants, RdRPs are recruited to aberrant RNAs or cleaved target mRNAs to 
synthesize the complementary strand, which results in dsRNA (Ghildiyal and Zamore 
2009; Lee et al. 2010). These dsRNAs can then be cut into small RNA duplex by Dicer. 
In C. elegans, however, secondary siRNA biogenesis is Dicer in-dependent as shown by 
in vivo and in vitro results (Fig 1.1) (Aoki et al. 2007; Pak and Fire 2007; Sijen et al. 
2007). There are four members of RdRP in C. elegans, EGO-1, RRF-1, RRF-2 and RRF-
3 (Smardon et al. 2000). The function of RRF-2 is still unclear (Sijen et al. 2001), RRF-3 
is required for ERGO-1 26G RNA biogenesis (Gent et al. 2009; Gu et al. 2009; Pavelec 
et al. 2009; Gent et al. 2010). EGO-1 is required for germline development and 
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synthesizing secondary siRNAs for both exo-siRNA and endo-siRNA pathways (Fig 1.1 
and 1.4) (Smardon et al. 2000; Claycomb et al. 2009; Gu et al. 2009). EGO-1 is essential 
for CSR-1 22G RNA pathway which is required for proper chromosome segregation. 
Surprisingly, it is still not clear what is the primary siRNA for the CSR-1 22G RNA 
pathway. RRF-1 is the major RdRP in somatic tissues and uses target mRNAs as 
templates to synthesize antisense secondary siRNAs, which determines the distinct 
distribution of secondary siRNAs polarity (5’→3’ on the antisense strand) (Sijen et al. 
2001; Pak and Fire 2007; Sijen et al. 2007). The secondary siRNAs are more abundant 
near the trigger region (Pak and Fire 2007; Sijen et al. 2007; Yang et al. 2012). Since the 
interaction between RDE-1 and RRF-1 has not been identified, it is not clear what is the 
signal for RRF-1 recruitment, but it does not seem to be the cleaved target mRNA 
generated by the slicer activity of RDE-1 (Pak et al. 2012).  Both rrf-1 and ego-1 are 
required for endo-siRNA biogenesis (Gu et al. 2009; Gent et al. 2010; Vasale et al. 2010). 
Sequential roles of RdRPs in endo-siRNA pathways have been proposed: rrf-3 is required 
for primary endo-siRNA biogenesis while rrf-1 and ego-1 are required for secondary 
endo-siRNA biogenesis (Gent et al. 2010; Vasale et al. 2010). It is worth noting that even 
rrf-1 and ego-1 mainly function in the soma and germline respectively, redundancy has 
been observed both in the exo-RNAi and the endo-RNAi pathways (Gu et al. 2009; Pak 
et al. 2012).       
 
RNA helicases 
RNA helicases comprise a large protein family that is involved in virtually all aspects of 
RNA metabolism. Although RNA helicases possess highly conserved domains, different 
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enzymes catalyze a wide spectrum of biochemical activities, including RNA duplex 
unwinding, protein displacement from RNA and strand annealing (Jankowsky and 
Fairman 2007). From multiple genetic screens and RNAi-based screens, several RNA 
helicases are found to be required for RNAi and transgene silencing in C. elegans 
(Tijsterman et al. 2002; Duchaine et al. 2006) and other organisms (Wu-Scharf et al. 
2000; Garcia et al. 2012). For example, DEAD-box RNA helicase MUT-14 is required to 
trigger gene silencing by short antisense RNAs. However, most of these studies focused 
on the genetic analysis of RNA helicase mutants. The progress to determine RNA 
substrates and interacting factors of RNA helicases in RNAi pathway seems still slow. 
Through mutational and structural analyses, enzymatic activities of helicase have been 
allocated to its motifs (Jankowsky and Fairman 2007). However, the results of in vitro 
biochemical analyses were hampered by the presence of residual catalytic activities. An 
extensive mutational analysis on the helicase domain with physiological expression level 
in vivo could provide more reliable interpretation on the function of different motifs in 
RNA helicases.  
 
Connection between transgene silencing and RNAi 
The Rde (RNAi defective) genes described in this study were identified from a pilot 
genetic screen for transgene desilencing mutants. Transgene silencing and RNAi have 
been shown to share many common factors (Fig 1.5) (Grishok et al. 2005; Kim et al. 
2005). In C. elegans, high-copy transgenes are established by microinjection of DNA 
containing genes of interest into the gonadal syncytium. Through random recombination, 
injected DNAs can form transmittable extrachromosomal arrays. During the random 
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recombination, the integrity of the gene within the transgenic array may be disrupted. 
Aberrant RNAs could be utilized as the template to form dsRNAs which are substrates of 
the RNAi machinery (Kelly et al. 1997; Montgomery and Fire 1998; Luo and Chen 2007). 
Despite the triggers of initial silencing are different from RNAi, transgene silencing 
pathway eventually, if not completely, utilizes the RNAi machinery to silence transgenes 
(Fig 1.5). 
 
Genetic screen for genes involved in RNAi 
Many genetic screens have been performed to identify novel Rde genes. The results are 
fruitful but were not able to cover every aspect of RNAi. The simplest screen is to feed 
mutagenized worms with dsRNA triggers targeting essential genes, and those “escapers” 
are Rde mutants (Tabara et al. 1999). Rde mutants will be viable but not those RNAi-
competent animals. One pitfall of this kind of screen is that many genes involved in 
uptake of dsRNA will also be considered as Rde genes (Winston et al. 2002). To 
eliminate these false positive hits, Rde mutants were further tested by direct injection of 
dsRNA which is considered as a more efficient strategy to induce RNAi. rde-1 and rde-4 
(required for dsRNA cleavage) were identified from this kind of screen (Tabara et al. 
1999). By performing secondary genetic screen, false positive hits were avoided. But Rde 
mutants with partial loss of RNAi functionality were also eliminated from further study.  
Another approach of searching for genes required for RNAi is to screen for genes 
required for transgene silencing. Several groups have utilized transgene desilencing 
phenotype to study RNAi related genes (Grishok et al. 2005; Kim et al. 2005; Fischer et 
al. 2008). Those studies usually use strains expressing two transgenes, a marker and 
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another transgene producing RNAi triggers. The marker transgene gave an easily 
observable phenotype (for example: GFP). The other transgene produced transcripts that 
can form dsRNAs. This approach seems to be not sensitive enough to identify mutants 
with weak Rde phenotype, presumably due to highly expressed triggers.  
Therefore, identification of novel components of RNAi machinery relies on a 
model with high sensitivity but without requirement of trigger delivery.  
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Figure 1.1. Exogenous RNAi pathway in C. elegans.
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Figure 1.2. Micro-RNA pathway in C. elegans.
14 
 
      
 
 
 
 
 
 
Figure 1.3. Simplified piRNA pathway in C. elegans. Adopted from (Gu et al. 2012). The 
identities of several components are not discovered yet. 
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Figure 1.4. Endogenous RNAi pathway in C. elegans. ERGO-1 26G small RNAs are enriched 
in oocytes and early embryos. ALG-3/4 26G small RNAs are enriched in sperms. The triggers for 
CSR-1 22G small RNAs are not discovered yet. 
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Figure 1.5. Transgene silencing shares similar molecular mechanism with RNAi.  
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Chapter 2 
 
The RDE-10/RDE-11 complex triggers RNAi induced mRNA 
degradation by association with target mRNA in C. elegans 
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Abstract 
The molecular mechanisms for target mRNA degradation in C. elegans undergoing RNA 
interference (RNAi) are not fully understood.  Using a combination of genetic, proteomic 
and biochemical approaches, we report a divergent RDE-10/RDE-11 complex that is 
required for RNAi in C. elegans. Genetic analysis indicates that the RDE-10/RDE-11 
complex acts in parallel of nuclear RNAi.  Association of the complex with target mRNA 
is dependent on RDE-1 but not RRF-1, suggesting that target mRNA recognition depends 
on primary but not secondary siRNA.  Furthermore, RDE-11 is required for mRNA 
degradation subsequent to target engagement.  Deep sequencing reveals a 5-fold decrease 
in secondary siRNA abundance in rde-10 and rde-11 mutant animals, while primary 
siRNA and micro-RNA biogenesis is normal. Therefore, the RDE-10/RDE-11 complex is 
critical for amplifying the exogenous RNAi response. Our work uncovers an essential 
output of the RNAi pathway in C. elegans.  
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Results and discussion 
rde-10 and rde-11 are required for transgene silencing and RNAi in C. elegans 
We established a transgene (hjIs21) in C. elegans that expressed an ATGL-1::GFP fusion 
protein under the control of the vha-6 promoter. The vha-6 promoter is active in intestinal 
cells from embryonic stage to adult (Oka et al. 2001).  Interestingly, hjIs21 is gradually 
silenced during larval development such that the ATGL-1::GFP fusion protein is visible 
in L1 but not L4 animals (Fig. 2.1A).  We measured the mRNA transcript level from the 
hjIs21 transgene by quantitative PCR and found that it was reduced by 5-fold in L4 
animals (Fig. 2.1B). The hjIs21 transgene undergoes a unique cycle of de-silencing and 
silencing in every generation.  We reasoned that identification of genes that are required 
for silencing hjIs21 may reveal novel regulators of transgene silencing. Therefore, we 
mutagenized animals carrying the hjIs21 transgene with EMS and screened for mutant 
alleles that conferred ATGL-1::GFP expression in adult animals. From this screen, we 
recovered two new alleles of rde-1, which suggests that the RNA interference (RNAi) 
pathway is required for silencing the hjIs21 transgene. Accordingly, mutant animals that 
carried the rde-1(ne300) reference allele could also increase the mRNA transcript level of 
the hjIs21 transgene and restored ATGL-1::GFP expression in the larval L4 stage (Fig. 
2.1A and B).  Our results suggest that the canonical RNAi pathway is indeed involved in 
silencing hjIs21 and trigger degradation of atgl-1::gfp mRNA.  We also identified two 
novel genes: rde-10 and rde-11 from our genetic screen. The hjIs21 mRNA levels in 
these two mutants were elevated in the L4 stage (Fig. 2.1A&B). In addition, rde-10 and 
rde-11 mutants failed to undergo RNAi by feeding E. coli that expressed double-stranded 
RNA targeting the endogenous pos-1 and nhr-23 genes (Fig. 2.1C and Table 2.1). 
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Molecular cloning revealed lesions of 3 recessive alleles of rde-10 and 1 recessive allele 
of rde-11 (Fig. 2.2A and 2.2B). The transgene silencing (Fig. 2.1A) and Rde phenotypes 
(Fig. 2.1C) of rde-10 and rde-11 mutant animals can be rescued by single copy 
transgenes expressing wild-type RDE-10 and RDE-11, respectively. Taken together, our 
results strongly suggest that rde-10 and rde-11 are two novel genes that are required for 
transgene silencing and RNAi in C. elegans.  
The rde-10 and rde-11 genes do not have orthologs outside the Caenorhabditis 
genus. rde-10 encodes a protein without any conserved domain, while rde-11 encodes a 
protein with a RING-type zinc finger domain, based on sequence homology search by 
SMART (Letunic et al. 2009).  The rde-10 and rde-11 mutants have no defect in fertility, 
no chromosome non-disjunction (Him) phenotype and no apparent defect in reproductive 
development, which suggests that rde-10 and rde-11 are unlikely to be required for 
miRNA and piRNA pathways. In rde-10 mutant animals, we also detected NRDE-3::GFP 
in the nucleus (Fig. 2.3), suggesting that the nuclear RNAi pathway is intact.  
 
rde-10 and rde-11 act in parallel of the nuclear RNAi pathway 
To address whether rde-10 and rde-11 are required for RNAi ubiquitously, we performed 
RNAi to silence genes that are expressed in different tissues. Surprisingly, rde-10 and 
rde-11 mutant animals show variable degree of RNAi resistance (Table 2.1). They are 
resistant to RNAi against pos-1, nhr-23 and unc-15 but are only partially resistant to 
RNAi against unc-22 and lir-1, which caused a twitcher phenotype and larval lethality, 
respectively (Table 2.1).  Incomplete RNAi resistance in rde-10 and rde-11 mutants was 
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not dependent on target tissues since unc-15 and unc-22 were both expressed in body 
wall muscles.  We hypothesize that rde-10 and rde-11 act in parallel of additional RNAi 
effector pathways that contribute differentially toward gene silencing on a gene-specific 
or RNAi trigger-specific basis.   
RNAi mediated gene silencing in C. elegans can occur both in the cytoplasm and 
the nucleus (Guang et al. 2008). It has been reported that nrde-3 mutants are defective for 
nuclear RNAi but not cytoplasmic RNAi (Guang et al. 2008).  Accordingly, nrde-3 
mutants are sensitive to unc-22 RNAi (Table 2.1). However, rde-10;nrde-3 and rde-
11;nrde-3 double mutants were resistant to unc-22 RNAi while rde-10; rde-11 double 
mutants remained partially sensitive to unc-22 RNAi (Table 2.1).  Our results suggest 
that rde-10 and rde-11 act in the same genetic pathway for cytoplasmic RNAi and in 
parallel of the nuclear RNAi pathway.  Consistent with this notion, we found that lir-1 
RNAi caused lethality in rde-10 and rde-11 mutants, as a result of nuclear RNAi against 
the nuclear-localized lir-1::lin-26 polysictronic RNA and a loss of lin-26 function (Table 
2.1).  
To further clarify the relative contribution of nrde genes, rde-10 and rde-11 for 
RNAi, we quantitated the endogenous mRNA levels of unc-15 in different genetic 
backgrounds after unc-15 RNAi. Using the unc-15 mRNA level in rde-1(ne300) mutant 
as a reference, we observed >90% reduction of unc-15 mRNA in wild-type animals (Fig. 
2.4A). However, in rde-10 and rde-11 mutants, the mRNA levels were ~19-fold higher 
than that in wild-type animals. This indicates that rde-10 and rde-11 are required for 
efficient silencing of endogenous targets by RNAi. We noted that the nrde-3 mutant was 
still proficient in cytoplasmic RNAi, which caused a ~80% reduction of unc-15 mRNA 
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after RNAi (Fig. 2.4A).  The rde-10;rde-11 double mutant had similar levels of residual 
unc-15 mRNA after RNAi as rde-10 and rde-11 single mutants (Fig. 2.4A). In contrast, 
we observed significant additive effect of RNAi deficiency in the rde-10;nrde-3 double 
mutants. As a result, the level of unc-15 mRNA in the rde-10;nrde-3 mutant is 
comparable to that in the rde-1 mutant (Fig. 2.4A). This additive effect can be reversed 
by introducing a wild-type nrde-3 transgene into the rde-10;nrde-3 double mutant (Fig. 
2.4A). Additional experiments using unc-22 RNAi support the same conclusion, though 
the unc-22 RNAi trigger seemed to induce nuclear RNAi more efficiently (Fig. 2.4B).  
Taken together, we conclude that rde-10 and rde-11 function in the same genetic pathway 
that acts in parallel of the nuclear RNAi pathway.  
 
RDE-10 and RDE-11 form a novel protein complex 
We used a proteomics approach to address whether RDE-10 interacts with previously 
characterized RNAi pathway components. Using a single copy transgenic strain that 
expressed a FLAG-epitope tagged RDE-10, we affinity purified RDE-10 from a worm 
population enriched with L4 stage animals, followed by Multi-dimensional Protein 
Identification Technology (MudPIT) analysis. Consistent with our genetic analysis, RDE-
11 was identified as a major RDE-10 interacting protein (Fig. 2.5A).  We also detected 
RSD-2, which is required for systemic RNAi (Tijsterman et al. 2004), and ERGO-1, 
which is required for biogenesis of some endogenous 26G siRNA (Gent et al. 2010; 
Vasale et al. 2010). Identification of these two proteins suggests that RDE-10 may be 
involved in both exogenous and endogenous RNAi pathways.  
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The physical association between RDE-10 and RDE-11 was further confirmed by 
co-immunoprecipitation assays.  We found that FLAG-epitope tagged RDE-10 could 
efficiently bind to HA-epitope tagged RDE-11 in worm lysates (Fig. 2.5B, lane 4).  To 
address whether RDE-10 can directly interact with RDE-11, we performed the same 
assay using in vitro translated proteins.   In the absence of Zn2+, we detected very weak 
but reproducible interaction between RDE-10 and RDE-11 (Fig. 2.5D, lane 5).  However, 
incubation of RDE-10 and RDE-11 in a buffer with 50µM Zn2+ strongly enhanced their 
interaction in vitro (Fig. 2.5D, lane 7).  Since RDE-11 possesses a RING-type Zinc finger 
domain, we speculate that RDE-11 requires zinc for proper folding and subsequent 
interaction with RDE-10. Indeed, the RING finger domain is required for RDE-11 
function since mutation in a single conserved cysteine in the RING finger could reduce 
its interaction with RDE-10 in vitro (Fig. 2.5C and 5E, lane 7) and abolish the rescuing 
activity of an rde-11 transgene in vivo (Fig. 2.1C, hjEx12) but not the protein stability 
(Fig. 2.2C).  Our results indicate that RDE-10 directly interacts with RDE-11 in a zinc-
dependent manner to form a stable complex.   
 
The RDE-10/RDE-11 complex associates with target mRNAs that are undergoing 
degradation 
To further test the hypothesis that RDE-10 and RDE-11 are required for cytoplasmic 
mRNA degradation, we asked if the RDE-10/RDE-11complex could associate with 
mRNAs targeted by RNAi. To this end, we generated rescuing single copy transgenes 
that expressed epitope-tagged RDE-10 or RDE-11 (Fig. 2.1C).  We chose elt-2 as the 
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target transcript for RNA co-immunoprecipitation (RNA-IP) assays (Fig. 2.6A). Animals 
were fed E. coli that expressed double-stranded RNA against elt-2 or an unrelated gene, 
prior to immunoprecipitation of RDE-10 or RDE-11.  Wild-type animals treated with elt-
2 RNAi showed an 80% reduction in elt-2 mRNA level (Fig. 2.7A).  Despite such low 
abundance of elt-2 mRNA, we detected ~170-fold enrichment of RDE-11 binding elt-2 
mRNA (Fig. 2.7B).  We also found that RDE-10 preferentially associated with elt-2 
mRNA in the presence or absence of RDE-11 (Fig. 2.7B).  Similar observations were 
made when we used dpy-28 as the target gene (Fig. 2.6B).  These results indicate that 
RDE-10 can be recruited to target mRNAs independent of RDE-11 and suggest that 
RDE-11 is not required for target mRNA recognition. As rde-11 mutant animals are 
RNAi defective (Fig. 2.7A), these results also indicate that the recruitment of RDE-10 
alone to target mRNAs is not sufficient to trigger RNAi.  
To test whether RDE-10 requires siRNA for target mRNA recognition, we also 
performed RDE-10 RNA-IP in rde-1(-) and rrf-1(-) animals.  While rde-1(-) animals are 
completely defective in primary and secondary siRNA biogenesis (Tabara et al. 2002), 
rrf-1(-) animals are unable to generate secondary siRNA in somatic tissues (Sijen et al. 
2001; Sijen et al. 2007). We found that RDE-10 failed to associate with target mRNAs in 
rde-1(-) animals (Fig. 2.7B, Fig. 2.6B).  In contrast, the association of RDE-10 with elt-2 
target mRNAs appeared to increase in rrf-1(-) animals (Fig. 2.7B). Such enhancement 
was not universal, since the association of RDE-10 with two additional somatically 
expressed mRNA targets,  flr-1 (Take-Uchi et al. 1998) and sel-1 (Pak and Fire 2007) 
was comparable in wild-type and rrf-1(-) animals (Fig. 2.7C).  Taken together, our results 
indicate that RDE-10 depends on primary but not secondary siRNA to engage target 
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mRNAs and support a model that RDE-10, and by extension RDE-11, acts downstream 
of RDE-1 and upstream of RRF-1. 
Next, we examined the integrity of target mRNAs that were associated with the 
RDE-10/RDE-11 complex. We performed quantitative PCR (qPCR) to measure the 
relative abundance of regions that are 5’ or 3’ to the RNAi trigger in RDE-10 associated 
elt-2 mRNAs. Interestingly, we observed a 70% reduction in their 3’ region in an RDE-
11 dependent manner (Fig. 2.7D).  Such preferential 3’ depletion was specific to elt-2 
mRNA that associated with RDE-10 and was not apparent in total RNA samples (Fig. 
2.7E).  Similar results were also observed in animals undergoing RNAi against dpy-28 
(Fig. 2.6C and D).  Since mature mRNAs possess a 5’ cap and a 3’ poly(A) tail, we next 
asked if these structures were preserved in RDE-10 target mRNAs.   Capped mRNA is 
resistant to the Terminator 5’-3’ exonuclease (TEX) unless pre-treated with the Tobacco 
Acid Pyrophosphatase (TAP). We found that mRNA transcripts of a house-keeping gene, 
gpd-3, and RDE-10 associated target elt-2 mRNA could both be degraded by TEX only 
after TAP pre-treatment (Fig. 2.7F and Fig. 2.9).  Therefore, our results suggest that 
RDE-10 associated target mRNAs are capped at the 5’ end.  
The instability of the 3’ region of RDE-10 associated target mRNAs could be 
caused by deadenylation.  To directly test this possibility, we repeated our RDE-10 RNA-
IP, followed by reverse transcription of bound mRNAs using random hexamer or 
oligo(dT) primers.   The former allowed detection of RNAs with or without a poly(A) tail 
while the latter allowed selective detection of poly(A) mRNAs.  The relative abundance 
of RDE-10 associated elt-2 mRNA was decrease by 40% when the oligo(dT) primer was 
used (Fig. 2.10A and B).  This decrease was observed in wild-type but not in rde-11 
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mutant animals.  Our results imply that the 3’ end of RDE-10 associated target mRNAs 
undergoes deadenylation and degradation in an RDE-11 dependent manner.  The 
retention of a 5’ cap of such mRNAs may confer transient stability of a region 5’ to the 
RNAi trigger, which can serve as a template for secondary siRNA synthesis.     
 
RDE-10 and RDE-11 are required for secondary siRNA biogenesis 
Our analysis so far placed the RDE-10/RDE-11 complex at a step between RDE-1 and 
RRF-1 in the exogenous RNAi pathway in C. elegans.  It is conceivable that the RDE-
10/RDE-11 complex is required for amplification of the RNAi response.  To test this 
hypothesis, we subjected wild-type, rde-10 and rde-11 mutant animals to RNAi against a 
somatic gene, sel-1, using a well-characterized trigger (Fig. 2.8A) (Pak and Fire 2007).  
We then purified small RNAs (21 to 24 nucleotides) from duplicate populations of 
animals and sequenced them using the Illumina platform.  Each biological sample yielded 
on average 11 million reads.  The abundance of primary siRNAs was comparable in wild-
type, rde-10 and rde-11 mutant animals (Fig. 2.8B, Table 2.2).  In contrast, a 5-fold 
decrease in secondary siRNAs was observed in rde-10 and rde-11 mutant animals (Fig. 
2.8C, Table 2.2). A detailed small RNA profiling revealed that 22G RNAs are the major 
secondary siRNA and reduced in rde-10 and rde-11 mutants (Fig. 2.11). It is conceivable 
that the residual secondary siRNAs can be loaded to secondary Argonautes (WAGOs) to 
sustain low level of cytoplasmic and nuclear RNAi.  Unlike the clear deficit in secondary 
siRNAs, we detected comparable levels of miRNAs (let-7, mir-1 and mir-66) (Reinhart et 
al. 2000; Lau et al. 2001; Lee and Ambros 2001) and a piRNA (21UR-1) (Ruby et al. 
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2006; Batista et al. 2008) in wild-type, rde-10 and rde-11 mutant animals (Fig. 2.8D and 
5E).  In addition, the levels of endogenous siRNAs complementary to F37D6.3 (WAGO-
1 target, (Gu et al. 2009)), E01G4.5 (NRDE-3 target, (Guang et al. 2008)) and hcp-1 
(CSR-1 target, (Claycomb et al. 2009)) were unchanged (Fig. 2.8E). Taken together, our 
results strongly suggest that the RDE-10/RDE-11 complex is required for secondary 
siRNA synthesis, which is critical for amplifying the exogenous RNAi response (Fig 
2.12). 
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Figure 2.1.  rde-10 and rde-11 are required for RNAi and transgene silencing.  (A) Schematic 
representation of the vha-6p::atgl-1b::gfp transgene (hjIs21).  Images of larval stage L1 or L4 wild-type 
animals carrying hjIs21 are shown, together with rde-1(ne300), rde-10(hj20), rde-11(hj37), rde-
10(hj20);hjSi10[rde-10(+)] and rde-11(hj37);hjSi116[rde-11(+)] L4 mutant animals carrying the same 
transgene.  Scale bar, 100µm.  (B) Quantitation of atgl-1::gfp mRNA level by real-time PCR.  The 
mRNA level in wild-type L1 animals was set as 1. Mean + standard deviation from triplicate reactions are 
shown. (C) Molting defect after nhr-23 RNAi in wild-type, rde-10(hj20), rde-11(hj37), rde-10(hj20); 
hjSi10[rde-10(+)], rde-11(hj37); hjSi116[rde-11(+)], rde-11(hj37);hjEx11[rde-11(+)] and rde-
11(hj37);hjEx12[rde-11(C203S)].  Mean + standard deviation from three independent experiments are 
shown. 
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Figure 2.2.  Gene structures of rde-10 and rde-11.  Exons are depicted in grey boxes.  Mutant alleles 
and corresponding changes in protein coding sequences are indicated.  (A) rde-10. (B) rde-11. (C) RDE-
11 transgenes hjEx11[rde-11(+)] and hjEx12[rde-11(C203S)] expression levels. 100 transgenic animals 
were used for western blot. 
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Figure 2.4.  rde-10 and rde-11 act in parallel of the nuclear RNAi pathway to silence target genes.  
(A)  Quantitation of endogenous unc-15 mRNA levels after RNAi in wild-type (WT), rde-1(ne300), rde-
10(hj20), rde-11(hj37), nrde-3(gg66), rde-10(hj20); rde-11(hj37), rde-10(hj20); nrde-3(gg66), and rde-
10(hj20); nrde-3(gg66); Is[nrde-3(+)] animals.  The mRNA level in rde-1 animals was set as 1.  Mean + 
standard deviation from three independent samples assayed in triplicates are shown.   (B) Quantitation of 
endogenous unc-22 mRNA levels after RNAi in wild-type and mutant animals as in (A).  Data are 
presented as in (A).  
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Figure 2.5.  RDE-10 directly interacts with RDE-11 to form a stable complex.  (A) MudPIT analysis 
on proteins co-immunoprecipitated with FLAG-tagged GFP::RDE-10 or GFP from worm extracts.  
dNASF (distributed normalized spectral abundance factors) indicates the relative abundance of proteins.  
Results are mean from 2 independent biological samples for GFP::RDE-10 and 3 independent biological 
samples for GFP.  (B)  Co-immunoprecipitation of HA-tagged RDE-11 with FLAG-tagged GFP::RDE-10 
but not FLAG-tagged GFP from worm lysates. (C) Schematic representation of RDE-11. The RING-type 
Zinc finger is shaded in light grey and the zinc coordinating Cys and His residues are enlarged. Cys203 is 
boxed. (D) Co-immunoprecipitation of in vitro translated HA-tagged RDE-11 with FLAG-tagged RDE-
10 in the presence or absence of Zn2+.  Direct interaction between RDE-10 and RDE-11 was strongly 
enhanced by Zn2+.  (E) Co-immunoprecipitation of in vitro translated wild-type and mutant HA-tagged 
RDE-11 with FLAG-tagged RDE-10 in the presence of Zn2+. Interaction between RDE-10 and RDE-11 
was impaired by the C203S mutation in the RING finger domain. 
  
33 
 
 
Figure 2.5.  RDE-10 directly interacts with RDE-11 to form a stable complex.   
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Figure 2.6.  The RDE-10/RDE-11 complex associates with dpy-28 mRNA targeted by RNAi.  
(A) Experimental scheme for RNA co-immunoprecipitation (RNA IP) assays.  (B) Target 
mRNA preferentially associated with RDE-10 in wild-type (WT), rde-11(hj37), rrf-1(pk1417) 
but not rde-1(ne300) animals as shown by real-time PCR.  Preferential association of target 
mRNA to RDE-11 was also observed in wild-type animals.  The levels of dpy-28 mRNA 5’ to 
the RNAi trigger were measured.  (C) Depletion of 3’ end of target mRNA associated with RDE-
10 in wild-type but not rde-11(hj37) animals.  The levels of dpy-28 mRNA 5’ to the RNAi 
trigger were set as 1.  (D) Comparison of relative abundance of dpy-28 mRNA 5’ and 3’ to the 
RNAi trigger.  Total RNA extracted from wild-type or rde-11(hj37) animals undergoing dpy-28 
RNAi was used.  All results are shown as mean + standard deviation from at least three 
independent samples assayed in triplicates.  
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Figure 2.6.  The RDE-10/RDE-11 complex associates with dpy-28 mRNA targeted by RNAi.   
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Figure 2.7.  The RDE-10/RDE-11 complex associates with mRNA targeted by RNAi.  (A) 
Quantitation of elt-2 mRNA levels by real-time PCR in wild-type (WT), rde-11(hj37) rde-1(ne300) or 
rrf-1(pk1417) animals undergoing elt-2 RNAi. Each strain also carried rde-10(hj20) and the rescuing 
single copy transgene hjSi10[rde-10(+)].  The mRNA levels of elt-2 in animals without RNAi treatment 
were set as 1 for each genotype. (B) Target mRNA preferentially associated with RDE-10 in wild-type 
(WT), rde-11(hj37), rrf-1(pk1417) but not rde-1(ne300) animals as shown by real-time PCR.  Preferential 
association of target mRNA to RDE-11 was also observed in wild-type animals.  The levels of elt-2 
mRNA 5’ to the RNAi trigger were measured.  The formula for calculating fold-enrichment is shown.  (C) 
Wild-type (WT) and rrf-1(pk1417) animals carrying hjSi10 were subject to flr-1 and sel-1 RNAi. Target 
mRNAs, but not the non-specific dpy-28 mRNA, preferentially associated with RDE-10 in wild-type and 
rrf-1animals. (D) Depletion of 3’ end of target mRNA associated with RDE-10 in wild-type but not rde-
11(hj37) animals.  The levels of elt-2 mRNA 5’ to the RNAi trigger were set as 1.  (E) Comparison of 
relative abundance of elt-2 mRNA 5’ and 3’ to the RNAi trigger.  Total RNA extracted from wild-type or 
rde-11(hj37) animals undergoing elt-2 RNAi was used.  (F) RDE-10 associated elt-2 mRNA was resistant 
to TEX unless pre-treated with TAP. RNA samples were subject to Tobacco Acid Pyrophosphatase (TAP) 
and/or Terminator 5’-3’ Exonuclease (TEX) treatments and were converted to cDNA and quantified with 
qPCR. The abundance of elt-2 mRNA (RNAi target) in the sample without any treatment was set to 1.    
All results are shown as mean + standard deviation from at least three independent samples assayed in 
triplicates. 
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Figure 2.7.  The RDE-10/RDE-11 complex associates with mRNA targeted by RNAi.   
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Figure 2.8.  RDE-10 and RDE-11 are required for secondary siRNA synthesis. (A) Schematic 
representation of sel-1 RNAi trigger and sel-1 mRNA. (B-E) The mean abundance of small RNAs from 
two independent populations of wild-type, rde-10(hj20) and rde-11(hj37) animals undergoing sel-1 RNAi 
is shown.  (B) Sense sel-1 siRNAs without TAP treatment.  (C) Antisense sel-1 siRNAs with TAP 
treatment.  (D) Selected microRNAs (mir). (E) Selected endogenous siRNAs and one 21U-RNA. RPMs 
were calculated by (reads_aligned_to_region / all_aligned_reads_for_sample) * 1000000. A 5’-ligation-
dependent method was used in library preparations. Small RNAs with 5’ monophosphate were better 
represented in libraries without TAP treatment. Small RNAs with 5’ triphosphate were better represented 
in libraries with TAP treatment.  
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Figure 2.8.  RDE-10 and RDE-11 are required for secondary siRNA synthesis.  
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Figure 2.10.  RDE-10 associates with target mRNAs that contain heterogeneous 3’ ends.  (A) The 
abundance of RDE-10 associated elt-2 target mRNA in wild-type and rde-11(hj37) animals was measured 
by real-time PCR.  RNA samples were reverse-transcribed using oligo(dT) or random hexamer primers 
and a region 5’ to the RNAi trigger amplified. Reduced abundance of oligo(dT) primed products indicate 
a depletion of poly(A) tailed elt-2 mRNA in wild-type but not rde-11 mutant animals. The abundance of 
elt-2 mRNA reverse transcribed by random hexamers was set as 1. Results are shown as mean ± standard 
deviation from at least three independent samples assayed in triplicates. (B) A model for RDE-10/RDE-
11 triggered heterogeneity of target mRNA 3’ ends. RDE-10 associated target mRNAs undergoes 
deadenylation and degradation in an RDE-11 dependent manner.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant. (A) Sense small RNA profile in 5’-to-trigger region. (B) Antisense small RNA 
profile in 5’-to-trigger region. (C) Sense small RNA profile in trigger region. (D) Antisense small RNA 
profile in trigger region. (E) Sense small RNA profile in 3’-to-trigger region. (F) Antisense small RNA 
profile in 3’-to-trigger region.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.11. Exo-RNAi induced elt-2 small RNA size and 5’ nucleotide distribution in WT, rde-10 
and rde-11 mutant.  
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Figure 2.12.  A model: RDE-10/RDE-11 complex in the exogenous RNAi pathway in C. elegans.
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Table 2.1. Susceptibility of worms to RNAi 
 
 
Nematodes of the indicated genotype were grown on E. coli (HT115) expressing double stranded RNA at 
20oC.  Strong phenotype of high penetrance was indicated by (++) and resistance to RNAi was indicated 
by (-).  Observations were made from at least three independent experiments.   
  
nuclear RNAi
pos-1 nhr-23 elt-2 unc-15 unc-22 lir-1
Genotype                        Phenotype
embryonic 
lethality
molt defect larval arrest paralysis twitcher larval lethality
Wild type (N2) ++ ++ ++ ++ ++ ++
rde-1(ne300) - - - - - -
rde-10(hj20) - - - - + +
rde-11(hj37) - - - - + +
nrde-3(gg66) +/++ + + +/++ +/++ -
rde-10(hj20);rde-11(hj37) - - - - + +
rde-10(hj20);nrde-3(gg66) - - - - - -
rde-11(hj37);nrde-3(gg66) - - - - - -
rde-10(hj20);nrde-3(gg66);Is[nrde-3(+)] - - - - + +
E. coli  mediated feeding RNAi
cytoplasmic RNAi + nuclear RNAi
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Table 2.2. Small RNAs in sel-1 locus after RNAi treatment 
 
Deep sequencing results of 21-24nt small RNAs that mapped to the sel-1 mRNA in wild-type and mutant 
animals undergoing sel-1 RNAi. 
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Material and Methods 
Strains and transgenes 
The wild-type strain was Bristol N2. All animals were raised at 20oC unless specified. The 
following alleles and transgenes were used: 
LGI: rde-10(hj18), rde-10(hj19), rde-10(hj20), rrf-1(pk1417) 
LGIV: rde-11(hj37) 
LGV: rde-1(ne300) 
LGX: nrde-3(gg66) 
hjSi10[rde-10p::3xFLAG-TEV-GFP::rde-10] 
Generated by MosSCI, outcrossed 2 times with N2. 
hjSi28[rde-10p::3xFLAG-TEV-GFP] 
Generated by MosSCI, outcrossed 2 times with N2. 
hjSi116[rde-10p::rde-11::TEV-3xFLAG] 
Generated by MosSCI, outcrossed 2 times with N2 
hjIs21[vha-6p::atgl-1b cDNA::GFP] 
 Generated by UV irradiation, outcrossed 5 times with N2  
ggIs1[nrde-3p::3xFLAG::GFP::nrde-3(+)] 
 a gift from Scott Kennedy 
hjEx11[rde-10p::rde-11 cDNA::mCherry-3xHA] 20ng/ul 
 tub-1::gfp (20ng/μl) and pBluescript (60ng/μl) injected into rde-11(hj37) 
hjEx12[rde-10p::rde-11 cDNA(C203S)::mCherry-3xHA] 20ng/ul 
 tub-1::gfp (20ng/μl) and pBluescript (60ng/μl) injected into rde-11(hj37) 
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Real-time PCR and primers 
RNA was extracted using TRI reagent (Molecular Research Center) according to manufacturer’s 
instructions. Genomic DNA contamination was removed using the TURBO DNA-free kit 
(AM1907, Ambion). cDNAs were synthesized using ImProm-II Reverse Transcription System 
(Promega). The cDNA was subject to real time PCR analysis using the IQ SYBR Green 
supermix (Bio-Rad) on an iCycler (Bio-Rad). Pimer sequences are described in Supplemental 
Material.   
 
Primer pairs (sequence from 5’ to 3’) for real-time PCR used in this study were: 
unc-15, ccagagagtccgcagatacc and ccgtgacgaaaatcttggag 
unc-22, ggaatgttaagagctgtgactgg and gggtgctccaaagcttgat 
gfp, tcagtggagagggtgaaggt and tcgagaagcattgaacacca 
rpl-32, agggaattgataaccgtgtccgca and tgtaggactgcatgaggagcatgt 
gpd-3, tggagccgactatgtcgttgag and gcagatggagcagagatgatgac 
elt-2 
5’ coding region: ctccaattgaacggcaaagt and cggttgcatggtagtttggt 
3’ coding region: agctgggttgatgatggttc and ccgcagctttggtttcat 
dpy-28 
5’ coding region: caaagtcgtcgattatctcgtt and caccaattccacatcgacac 
3’ coding region: gccttcataggcttcaagaca and catttttcgacgttgaatgc  
flr-1 
5’ coding region: cttctactgggctatcatgcaa and tttgtggtgttcagagggttt 
sel-1 
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5’ coding region: ctctggtatctgcggaagga and ctcatcttgctgtgatgtgacc 
Specificity of primers was examined by melting curves and sequencing of PCR products. 
Primer efficiency was tested with a dilution series of the template. 
 
Sequences used for small RNA analysis 
mir-1: UGGAAUGUAAAGAAGUAUGUA 
mir-66: CAUGACACUGAUUAGGGAUGUGA 
let-7: UGAGGUAGUAGGTTGUAUAGUU 
21UR-1: UGGUACGUACGUUAACCGUGC 
F37D6.3: chrI:10,486,644-10,487,373 
E01G4.5: chrII:13,472,179-13,473,970 
hcp-1: chrV:6,593,675-6,599,690 
 
Genetic Screen 
We mutagenized hjIs21 animals with ethyl methane-sulfonate (EMS) using standard procedures 
for mutants that expressed ATGL-1::GFP in the adult stage. We screened ~20,000 haploid 
genomes and isolated mutants that fell into at least three complementation groups. One of them 
was identified to be rde-1. Genetic mapping with the Hawaiian isolate CB4856 placed rde-
10(hj18) on LGI between snp_Y47G6A and snp_T28F2. RNAi screen and candidate gene 
sequencing identified a C to T mutation which causes a single amino acid substitution (S228F) in 
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Y47G6A.4. rde-10(hj19) and rde-10(hj20), both carrying a premature stop codon in Y47G6A.4, 
were later identified from this complementation group. We used hj20 as the reference allele. rde-
11(hj37) was mapped to an interval in LGIV that included B0564.11, which encoded a strong 
interacting partner of GFP::RDE-10.  Sequencing of B0564.11 in rde-11(hj37) identified a G to 
A mutation that yields a premature stop codon.  rde-10(hj20) and rde-11(hj37) were rescued by 
single copy transgenes hjSi10 and hjSi116, respectively. 
 
RNAi experiments 
RNAi was carried out as previously reported (Timmons et al. 2001). Bacterial clones expressing 
dsRNA were obtained from the Ahringer RNAi library except for dpy-28 (PCR product of 5’-
cgaaacgtgcttcaactag-3’ and 5’-atgtccatgtcgattattatcc-3’), sel-1 (PCR product of 5’-
tgcatggagccggaatcgga-3’ and 5’-tgcatcggcacttcctgact-3’) and flr-1 (PCR product of 5’-
ttggcagggaaaagctacat -3’ and 5’-ctcctcctcagcaactgcat -3’) RNAi clones.  For unc-15 and unc-22 
RNAi experiments, 10OD600 of bacteria was seeded on 100mm RNAi plates. Plates were left at 
room temperature overnight for dsRNA expression. 6000 eggs from egg preps were seeded on 
plates in triplicate for each strain. After 48 hrs at 20oC, worms were washed extensively with M9 
and RNA was extracted with TRI Reagent (Molecular Research Center).  For elt-2 RNAi 
experiments, 4000 synchronized L1 animals from egg preps were seeded on 100mm RNAi plates. 
Worms were collected after 46hrs at 20oC and RNA was extracted with TRI Reagent. 
 
Worm lysate preparation and immuno-precipitation for MudPIT 
Mixed-stage worms grown in liquid culture with E. coli HB101 were used for preparation of 
worm lysate and immuno-precipitation. Worms were collected and washed extensively with M9, 
56 
 
ground in liquid Nitrogen and added to IP buffer (20mM HEPES-KOH[pH7.5], 10mM KOAc, 
2mM Mg(OAc)2, 110mM KCl, 0.1% NP-40, 1x Protease Inhibitor(Sigma, P8340)). 3xFLAG 
tagged RDE-10 was purified by immunoprecipitation with agarose beads conjugated with anti-
FLAG antibodies. Immunoprecipitations were carried out at 4oC for 4hrs. GFP::RDE-10 or GFP 
were eluted from beads by TEV protease treatment at 4oC overnight in IP buffer. 
Acetone-precipitated proteins were urea-denatured, reduced, alkylated and digested with 
endoproteinase Lys-C (Roche) followed by modified trypsin (Promega) as described (Florens 
and Washburn 2006). Fully automated 10-step MudPIT runs were carried out on a linear ion trap 
mass spectrometer (Thermo Fisher Scientific) equipped with a nano-LC electrospray ionization 
source. Tandem mass (MS/MS) spectra were interpreted using SEQUEST (Eng et al. 1994) 
against a database consisting of 23714 non-redundant C. elegans proteins (NCBI, 2010-03-12 
release), 177 sequences for usual contaminants (such as keratins and proteolytic enzymes), as 
well as the sequences for FLAG-GFP and FLAG-GFP::RDE-10.  In addition, to estimate false 
discovery rates (FDR), each non-redundant protein entry was randomized (keeping the same 
length and amino acid composition) and these “shuffled” sequences were added to the forward 
sequences and searched at the same time. Peptide/spectrum matches were sorted and selected 
using DTASelect (Tabb et al. 2002). FDRs at the protein and peptide levels were both less than 
1%. To estimate relative protein levels, distributed Normalized Spectral Abundance Factors 
(dNSAFs) were calculated for each detected protein as described (Zhang et al. 2010). 
 
RNA Immuno-precipitation 
RDE-10 and RDE-11 RNA IP (RIP) were performed as previously described (Guang et al. 2008) 
with modifications. To isolate RDE-10 associated total RNAs after RNAi, synchronized L1 
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animals (from egg preps) were seeded onto 100mm RNAi plates and collected at L4 stage (~44-
46hrs at 20oC). Animals were sonicated in lysis buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 
2.5 mM MgCl2, 0.5% NP-40, and 10% glycerol, with proteinase inhibitor tablet EDTA-free 
(Roche) and RNaseOUT (Invitrogen)). 3xFLAG::GFP::RDE-10 was immunoprecipitated with 
Dynabeads M280 pre-coated with anti-FLAG antibody (Sigma, F1804). After extensive washes, 
3xFLAG::GFP::RDE-10 was eluted with 150 ug/mL 3xFLAG peptide.  Eluates were first 
incubated with Turbo DNase I (Ambion) at 37oC for 20 minutes. The RNAs were then purified 
by TRI Reagent, followed by isopropanol precipitation. cDNAs were generated from RNAs with 
ImProm-II Reverse Transcription System using a mixture of oligo(dT) and random hexamer 
primers.  For Fig. 2.10, RNA samples were split into two and reverse transcription performed 
with either oligo(dT) or random hexamer primers. qPCRs were performed as described above. 
Target mRNA enrichment was normalized by non-specific binding of gpd-3 mRNA. RDE-11 
RIP was performed in the same way as RDE-10 RIP.   
 
Antibodies 
Monoclonal antibodies against the FLAG epitope (clone M2; Sigma) and HA epitope (clone 
3F10; Roche) were used for Western blot. For immunoprecipitation anti-FLAG M2 Affinity Gel 
(A2220, Sigma) was used. 
 
RDE-10/RDE-11 Co-IP 
Strains used were rde-10(hj20); hjSi10; hjEx11 and hjSi28; hjEx11. Worms were ground in 
liquid Nitrogen and added to IP buffer (20mM HEPES-KOH[pH7.5], 10mM KOAc, 2mM 
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Mg(OAc)2, 110mM KCl, 0.1% NP-40, 1x Proteinase Inhibitor (Sigma, P8340)). 
3xFLAG::GFP::RDE-10 or 3xFLAG::GFP proteins were immuno-precipitated with anti-FLAG 
beads at 4oC for 2hrs and washed twice in IP buffer. To digest nucleic acid, beads were treated 
with 20 units of Benzonase (Sigma, E8263) in 1mL IP buffer for 30mins at room temperature. 
Beads were washed twice more in IP buffer. Proteins on beads were then eluted with 2x SDS 
buffer. Eluates were subject to Western blotting. 
 
In-vitro translation and pull-down assay 
The rde-10 and rde-11 cDNAs were cloned into pcDNA3.1 for expression of RDE-10::FLAG 
and RDE-11::HA fusion proteins. RDE-10 and RDE-11 recombinant proteins were synthesized 
separately using TnT T7 Coupled Reticulocyte Lysate System (L4610, Promega). Lysates 
containing RDE-10 and RDE-11 recombinant proteins were mixed together and diluted with 3 
volume of IP buffer (20mM HEPES-K[pH7.5], 50mM NaCl, 5mM MgCl2, 0.1% NP-40, with or 
without 50µM ZnSO4) plus Roche proteinase inhibitor (EDTA-free). Mixtures were incubated at 
37oC for 20mins and then incubated with anti-FLAG agarose beads (Sigma, A2220) at 4oC for 
1.5hrs. Beads were washed five times with 800µl IP buffer. Proteins on beads were eluted using 
2x SDS loading buffer.  Eluates were subject to Western blotting. 
 
Small RNA cloning and deep sequencing 
Synchronized L1 worms were grown on RNAi plates seeded with HT115 E. coli expressing a 
sel-1 RNAi trigger as previously described (Pak and Fire 2007). After 48hrs at 20oC, 40000 
worms were washed 5 times with 10ml M9, and then homogenized in Tri-reagent. Samples were 
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kept at -80oC. Purified total RNA were processed with MirVana kit (Invitrogen) for small RNA 
enrichment. Equal amount of small RNAs (20~30ug) were resolved on 15% TBE-Urea 
Acrylamide gels. Gels containing small RNAs of 21-24nt were cut out and purified with a small-
RNA PAGE Recovery Kit (Zymo Research, R1070). Each small RNA sample was split into two 
(one for TAP treatment and another untreated) and processed with the ScriptMiner Small RNA-
Seq Library Preparation Kit (Epicentre, SMMP1012). Libraries from different samples were 
indexed with RNA-Seq Barcode Primers (Epicentre, RSBC10948). Two biological samples of 
each condition (wild type, wild type + TAP, rde-10 mutant, rde-10 mutant + TAP, rde-11 mutant 
and rde-11 mutant + TAP) were used for library preparation.  A total of 12 libraries were pooled 
together and subject to Illumina HiSeq-50bp single read deep sequencing.  Sequencing reads 
were clipped with Fastx_clipper (v0.0.13) to remove adaptor sequence and aligned to the UCSC 
reference genome ce6 with Tophat (v1.4.0).  The aligned reads ranged from 10.7 to 13.3 million 
for each library. The coverageBed component of BEDtools (v2.12.0) was used to count the reads 
of each region and small RNAs. RPMs were calculated by (reads_aligned_to_region / 
all_aligned_reads_for_sample) * 1000000.  The data reported in this paper have been deposited 
in the Gene Expression Omnibus (GEO).  
 
Tobacco acid pyrophosphatase (TAP) and Terminator exonuclease (TEX) treatment of 
RDE-10 bound target mRNA 
Worms expressing FLAG-tagged RDE-10 (rde-10;hjSi10) were grown on elt-2 RNAi plates and 
then subject to RNA-IP. After phase separation, the aqueous phase of Tri-reagent treated samples 
was further purified with RNA clean & Concentrator-5 Kit (Zymo Research, R1015). The 
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purified RNA in nuclease-free water was evenly split into four samples. 15 units of TAP 
(Epicentre, T19100) or equal volume of nuclease-free water were added to each sample in TAP 
reaction buffer (final volume 25µl). Samples were incubated at 37oC for 1.5hrs. The RNA 
samples were then purified with RNA clean & Concentrator kit again. The TEX (Epicentre, 
TER51020) treatment was performed following vender’s Buffer A protocol. After TEX 
treatment, RNAs were purified with RNA clean & Concentrator kit and converted to cDNA with 
ImProm-II Reverse Transcription System (Promega). This was followed by real-time PCR using 
primers that amplified the 5’ coding region of elt-2. The relative amount of RNAs in each sample 
was normalized to the one without treatment.   
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Chapter 3 
A putative RNA helicase RDE-12 engages target mRNA to promote RNAi 
response amplification in novel cytoplasmic foci in C. elegans 
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Abstract 
In C. elegans, the RNAi response is enhanced through a unique process of siRNA amplification.  
The molecular mechanisms underlying such amplification are not completely understood. 
Argonaute protein RDE-1 binds primary siRNAs derived from dsRNA triggers and is guided to 
target mRNAs. This is followed by recruitment of RNA-dependent RNA polymerases (RdRPs) 
to synthesize secondary siRNA by using target mRNAs as templates. Here, through a genetic 
screen, we identified a putative DEAD-box RNA helicase, RDE-12, that functions upstream of 
RdRPs and downstream of RDE-1. RDE-12 engages target mRNAs and promotes secondary 
siRNA biogenesis in both the exogenous RNAi and the endogenous RNAi pathways. We further 
demonstrated that GFP::RDE-12 fusion protein forms cytoplasmic foci in the soma and resides 
in perinuclear P granules in the germline. Mutations that disrupt a nucleoporin domain and the 
catalytic residues of the helicase domain impair RDE-12 function in vivo.  We hypothesize that 
RDE-12 may act as a link between mRNA targeting and secondary siRNA synthesis in the RNAi 
pathway. 
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Results and discussion  
rde-12 is required for transgene silencing and RNAi in C. elegans 
A transgene (hjIs21) expressing ATGL-1::GFP fusion protein undergoes a unique cycle of 
desilencing and silencing in every generation (Yang et al. 2012). In L4 animals, the GFP fusion 
is not detectable (Fig. 3.1A). We identified one mutant allele defining the gene rde-12, which is 
required for transgene silencing in the reporter strain hjIs21 (Fig. 3.1A). From a genetic screen 
for mutants that are defective in transgene silencing, we identified the RDE-10/ RDE-11 protein 
complex that triggers RNAi-induced mRNA degradation by association with target mRNA 
(Yang et al. 2012). Here, we report the identification of rde-12 from the same screen (Fig.3.1A). 
We initially identified one nonsense allele, hj41. From a genetic non-complementation screen, 
we identified three additional alleles of rde-12 that failed to silence the reporter transgene 
(Fig.3.1B). rde-12 encodes a putative DEAD-box RNA helicase with a nucleoporin domain at 
the C-terminus (Fig. 3.1B) (Altschul et al. 2005; Marchler-Bauer et al. 2011). The nucleoporin 
domain is rich in phenylalanine (F) and glycine (G), FG repeats, and found in nucleoporins that 
form the nuclear pore complex. In C. elegans, transgene silencing and RNAi share common 
factors (Kim et al. 2005). To test whether rde-12 is required for RNAi, we performed RNAi to 
silence endogenous genes that are expressed in different tissues. rde-12(-) mutant animals fail to 
response to RNAi and can be rescued by single-copy transgenes expressing wild-type RDE-12 
(Table 3.1). Taken together, our results indicate that rde-12 is a novel gene required for 
transgene silencing and RNAi in C. elegans.    
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RDE-12 localized to cytoplasmic foci in soma and P granules in germline 
RDE-12 was localized to P granules in the germline based on a high-copy transgene (Sheth et al. 
2010). We established a single copy transgene that expressed fusion protein of green fluorescent 
protein (GFP) and full-length RDE-12. Expression of GFP::RDE-12 rescued the loss-of-function 
phenotypes of rde-12(-) mutant animals. GFP-RDE-12 is co-localized with P granules marker 
PGL-1 to perinuclear region in germline (Fig. 3.2A). P granules are germline specific 
cytoplasmic bodies with multiple putative functions. It has been proposed that P granules act as 
hydrophobic barriers that will slow down mRNAs diffusion when newly synthesized mRNAs 
exit nuclearpores and enter the cytoplasm (Sheth et al. 2010; Updike et al. 2011). The extended 
stay of mRNAs in P granules may allow regulatory factors (for example, Argonaute proteins) to 
find their target mRNAs. Multiple small regulatory RNA pathway components have been shown 
to localize to P granules (Updike and Strome 2010; Phillips et al. 2012). The localization of 
RDE-12 is consistent with its function in the germline RNAi pathway (Table 3.1). Though P 
granules are absent in the soma, GFP::RDE-12 remains and forms cytoplasmic foci. Processing 
bodies (P bodies) are cytoplasmic foci that are involved in mRNA degradation (Balagopal and 
Parker 2009). RNAi pathway components like Argonaute proteins were localized to P bodies 
(Sen and Blau 2005). Since RDE-12 is required for RNAi, it is possible that RDE-12 is localized 
to P bodies. Surprisingly, only a few RDE-12 foci overlapped with P bodies (Fig. 3.2B). 
Therefore, RDE-12 marks a population of cytoplasmic foci that are distinct from P bodies.  
 
RDE-12 engages mRNAs targeted by RNAi 
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 We showed that RDE-10/11 protein complex associates with target mRNAs that are undergoing 
degradation (Yang et al. 2012). Since RDE-12 is predicted to be an RNA helicase, we 
hypothesize that RDE-12 may also associate with target mRNAs. To test this possibility, we 
performed RNA co-immunoprecipitation to examine whether RDE-12 can engage target mRNAs 
in response to exogenous RNAi. The  elt-2 mRNA level was reduced by 80% after RNAi knock 
down (Yang et al. 2012). Despite low abundance of the elt-2 mRNA, we detected ~130-fold 
more of the elt-2 mRNA bound by RDE-12 (Fig. 3.3A). Similar result was observed when dpy-
28 was targeted by RNAi (Fig. 3.3A).  
 To test whether RDE-12 requires siRNA for target mRNA recognition, we also 
performed RDE-12 RNA IP in rde-1(-) and rrf-1(-) animals. While rde-1(-) animals are defective 
in primary and secondary siRNA biogenesis (Tabara et al. 2002; Pak et al. 2012), rrf-1(-) 
animals are defective in generating secondary siRNA in somatic tissues (Pak et al. 2012). We 
found that RDE-12 failed to associate with flr-1 target mRNAs in rde-1(-) animals (Fig 3.3B). In 
contrast, RDE-12 was still able to engage target mRNAs in rrf-1(-) animals (Fig 3.3B). We 
previously showed that rde-10(-) animals were also partially defective in secondary siRNA 
biogenesis (Yang et al. 2012). We observed similar association of RDE-12 with target mRNA in 
rde-10(-) animals (Fig 3.3B) which suggested RDE-12 act upstream of RDE-10. Taken together, 
our results indicate that RDE-12 depends on primary but not secondary siRNA to engage target 
mRNAs and support a model that RDE-12 act downstream from RDE-1 and upstream of RDE-
10 and RRF-1. 
 
RDE-12 is required for secondary siRNA biogenesis 
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Our analysis so far placed RDE-12 at a step between RDE-1 and RRF-1 in the exogenous RNAi 
pathway in C. elegans.  It is conceivable that the RDE-12 complex is required for amplification 
of the RNAi response.  To test this hypothesis, we subjected wild-type and rde-12(-) mutant 
animals to RNAi against a somatic gene, sel-1, using a well-characterized trigger (Fig. 3.4A) 
(Pak and Fire 2007).  We then purified small RNAs (~20 to 26 nucleotides) from duplicate 
populations of animals and profiled small RNAs by deep sequencing.  Each biological sample 
yielded on average 21 million reads.  The abundance of primary siRNAs was comparable in 
wild-type and rde-12(-) mutant animals (Fig. 3.4A).  In contrast, about 50-fold decrease in 
secondary siRNAs was observed in rde-12(-) mutant animals (Fig. 3.4B). It is conceivable that 
the residual secondary siRNAs can be loaded to secondary Argonautes (WAGOs) to sustain low 
level of RNAi effect. Taken together, our results strongly suggest that RDE-12 is required for the 
secondary siRNA synthesis, which is critical for amplifying the exogenous RNAi response. 
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Figure 3.1.  RDE-12 is a putative DEAD-box RNA helicase that required for transgene silencing.  
(A) Schematic representation of the vha-6p::atgl-1b::gfp transgene (hjIs21).  Images of larval stage L4 
wild-type animals carrying hjIs21 are shown, together with rde-12(hj41) L4 mutant animals carrying the 
same transgene.  Scale bar, 100µm.  (B) Gene structures of rde-12.  Mutant alleles and corresponding 
changes in protein coding sequences are indicated. Helicase core domain is highlighted in green and 
nucleoporin domain is highlighted in purple. 
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Figure 3.2. RDE-12 localized in cytoplasmic foci in soma and P granules in germline. (A) germline 
showing co-localization of GFP::RDE-12 with P granules maker mRuby::PGL-1. (B) Partial co-
localization of GFP::RDE-12with P bodies marker mRuby::DCAP-1. Autofluorescence in intestinal cells 
is in purple. Bar, 10um   
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Figure 3.3. RDE-12 associates with mRNA targeted by RNAi. (A) Animals were subjected to elt-2 and 
dpy-28 RNAi separately. Target mRNAs, but not the nonspecific mRNA, preferentially associated with 
RDE-12. (B) Animals were subjected to flr-1 RNAi. Target mRNAs preferentially associated with RDE-
12 in wild-type, rrf-1(pk1417), rde-10(hj20) but not rde-1(ne300) animals.  
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Figure 3.4. RDE-12 is required for secondary siRNA synthesis. The mean abundance of reads from 
two independent populations of animals undergoing sel-1 RNAi is shown. (A) Sense sel-1 siRNAs reads. 
(B) Antisense sel-1 siRNAs reads.  
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Table 3.1. Susceptibility of worms to RNAi 
  
E. coli-mediated feeding RNAi 
pos-1 nhr-23 unc-15 
embryonic lethality molt defect paralysis 
Wild type ++ ++ ++ 
rde-1(ne300) - - - 
rde-12(hj41) - - - 
rde-12(hj41);hjSi394[rde-
12(+)] ++ ++ ++ 
rde-12(hj41);hjSi395[rde-
12(+)] ++ ++ ++ 
 
Nematodes of the indicated genotype were grown on E. coli (HT115) expressing double stranded RNA at 
20oC.  Strong phenotype of high penetrance was indicated by (++) and resistance to RNAi was indicated 
by (-).   
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Material and Methods 
Strains and transgenes 
The wild-type strain was Bristol N2. All animals were raised at 20oC unless specified. The 
following alleles and transgenes were used: 
LGI: rde-10(hj18), rrf-1(pk1417) 
LGV: rde-1(ne300), rde-12(hj41) 
hjSi394[letm-1p::3xFLAG_TEV::rde-12] 
Generated by MosSCI (LG II), outcrossed 2 times with N2. 
hjSi395[dpy-30p::gfp::rde-12] 
Generated by MosSCI (LG II), outcrossed 2 times with N2. 
hjSi396[dpy-30p::mRuby::pgl-1] 
Generated by MosSCI (LG I), outcrossed 2 times with N2 
hjSi397[dpy-30p::mRuby::dcap-1] 
Generated by MosSCI (LG I), outcrossed 2 times with N2 
hjIs21[vha-6p::atgl-1b cDNA::GFP] 
 Generated by UV irradiation (LG X), outcrossed 5 times with N2  
 
Real-time PCR and primers 
RNA was extracted using TRI reagent (Molecular Research Center) according to manufacturer’s 
instructions. Genomic DNA contamination was removed using the TURBO DNA-free kit 
(AM1907, Ambion). cDNAs were synthesized using ImProm-II Reverse Transcription System 
(Promega). The cDNA was subject to real time PCR analysis using the IQ SYBR Green 
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supermix (Bio-Rad) on an iCycler (Bio-Rad). Pimer sequences are described in Supplemental 
Material.   
 
Primer pairs (sequence from 5’ to 3’) for real-time PCR used in this study were: 
gpd-3, tggagccgactatgtcgttgag and gcagatggagcagagatgatgac 
elt-2 
5’ coding region: ctccaattgaacggcaaagt and cggttgcatggtagtttggt 
dpy-28 
5’ coding region: caaagtcgtcgattatctcgtt and caccaattccacatcgacac 
flr-1 
5’ coding region: cttctactgggctatcatgcaa and tttgtggtgttcagagggttt 
sel-1 
5’ coding region: ctctggtatctgcggaagga and ctcatcttgctgtgatgtgacc 
Specificity of primers was examined by melting curves and sequencing of PCR products. 
Primer efficiency was tested with a dilution series of the template. 
 
Genetic Screen 
We mutagenized hjIs21 animals with ethyl methane-sulfonate (EMS) using standard procedures 
for mutants that expressed ATGL-1::GFP in the adult stage. We screened ~20,000 haploid 
genomes and isolated mutants that fell into at least three complementation groups. One of them 
was identified to be rde-1. Genetic mapping with the Hawaiian isolate CB4856 placed rde-
12(hj41) on LGV. RNAi screen and candidate gene sequencing identified a C to T mutation 
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which causes a premature stop in F58G11.2. Then we performed a non-complementation screen 
for additional alleles of rde-12. At the end we identified two more non-sense alleles and one 
allele with mutation at splice donor (hj57, hj58 and hj59).We used hj41 as the reference allele.  
 
RNAi experiments 
RNAi was carried out as previously reported (Timmons et al. 2001). Bacterial clones expressing 
dsRNA were obtained from the Ahringer RNAi library except for dpy-28 (PCR product of 5’-
cgaaacgtgcttcaactag-3’ and 5’-atgtccatgtcgattattatcc-3’), sel-1 (PCR product of 5’-
tgcatggagccggaatcgga-3’ and 5’-tgcatcggcacttcctgact-3’) and flr-1 (PCR product of 5’-
ttggcagggaaaagctacat -3’ and 5’-ctcctcctcagcaactgcat -3’) RNAi clones.   
 
RNA Immuno-precipitation 
RDE-12 RNA IP (RIP) were performed as previously described (Guang et al. 2008) with 
modifications. To isolate RDE-12 associated total RNAs after RNAi, synchronized L1 animals 
(from egg preps) were seeded onto 100mm RNAi plates and collected at L4 stage (~42hrs at 
20oC). Animals were sonicated in lysis buffer (20 mM Tris-HCl, pH 7.5, 200 mM NaCl, 2.5 mM 
MgCl2, 0.5% NP-40, and 10% glycerol, with proteinase inhibitor tablet EDTA-free (Roche) and 
RNaseOUT (Invitrogen)). 3xFLAG::RDE-12 was immunoprecipitated with Dynabeads M280 
pre-coated with anti-FLAG antibody (Sigma, F1804). After extensive washes, 3xFLAG::RDE-12 
was eluted with 150 ug/mL 3xFLAG peptide.  Eluates were first incubated with Turbo DNase I 
(Ambion) at 37oC for 20 minutes. The RNAs were then purified by TRI Reagent, followed by 
isopropanol precipitation. cDNAs were generated from RNAs with ImProm-II Reverse 
Transcription System using a mixture of oligo(dT) and random hexamer primers.  qPCRs were 
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performed as described above. Target mRNA enrichment was normalized by non-specific 
binding of gpd-3 mRNA.  
 
Antibodies 
Monoclonal antibodies against the FLAG epitope (clone M2; Sigma) were used for IP and 
Western blot. For immunoprecipitation anti-FLAG M2 Affinity Gel (A2220, Sigma) was used. 
 
 
Small RNA cloning and deep sequencing 
Synchronized L1 worms were grown on RNAi plates seeded with HT115 E. coli expressing a 
sel-1 RNAi trigger as previously described (Pak and Fire 2007). After 48hrs at 20oC, 40000 
worms were washed 5 times with 10ml M9, and then homogenized in Tri-reagent. Samples were 
kept at -80oC. Purified total RNA were processed with MirVana kit (Invitrogen) for small RNA 
enrichment. Equal amount of small RNAs (20~30ug) were resolved on 15% TBE-Urea 
Acrylamide gels. Gels containing small RNAs of 21-24nt were cut out and purified with a small-
RNA PAGE Recovery Kit (Zymo Research, R1070). Each small RNA sample was split into two 
(one for TAP treatment and another untreated) and processed with the ScriptMiner Small RNA-
Seq Library Preparation Kit (Epicentre, SMMP1012). Libraries from different samples were 
indexed with RNA-Seq Barcode Primers (Epicentre, RSBC10948). Two biological samples of 
each condition (wild type, rde-12 mutant, wild type+RNAi and rde-12 mutant+RNAi) were used 
for library preparation.  A total of 8 libraries were pooled together and subject to Illumina HiSeq-
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50bp single read deep sequencing.  Sequencing reads were clipped with Fastx_clipper (v0.0.13) 
to remove adaptor sequence and aligned to the UCSC reference genome ce6 with Tophat (v1.4.0).  
The aligned reads ranged from 20.0 to 24.1 million for each library. The coverageBed 
component of BEDtools (v2.12.0) was used to count the reads of each region and small RNAs. 
RPMs were calculated by (reads_aligned_to_region / all_aligned_reads_for_sample) * 1000000.   
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Chapter 4 
 
Conclusion and perspective 
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In the work described here, we identified the divergent RDE-10/RDE-11 complex as an 
essential output for exogenous RNAi in C. elegans.  Our genetic, proteomic and biochemical 
data indicate that the RDE-10/RDE-11 complex is recruited to target mRNAs for their 
degradation, downstream of the Argonaute RDE-1 and primary siRNA biogenesis.  Recruitment 
of the RDE-10/RDE-11 complex also plays an important role in supporting secondary siRNA 
synthesis.  Taken together, the RDE-10/RDE-11 complex links the amplification of the RNAi 
response to the initial processing and utilization of the exogenous double-stranded RNA triggers 
(Fig. 2.12).   
Multiple parallel pathways may operate downstream of the primary RNAi response that 
is dependent on DCR-1/dicer, RDE-1, RDE-4 and their associated proteins (Tabara et al. 2002; 
Duchaine et al. 2006; Yigit et al. 2006).  Although the RNAi response in rde-10 and rde-11 
mutant animals is severely blunted, the quantitative analysis of target mRNAs suggests that 
additional RNAi outputs remain operational.  This can be attributed to residual secondary siRNA 
synthesis in rde-10 and rde-11 mutant animals.  We postulate that recruitment of RRF-1 to target 
mRNAs, which is required for secondary siRNA synthesis, is strongly promoted by prior 
engagement of the RDE-10/RDE-11 complex to target mRNAs.  However, RRF-1 may be 
recruited by additional mechanisms, perhaps through recognition of RDE-1 that is bound to 
target mRNAs.  We note that high concentration of exogenous double-stranded RNA triggers 
introduced by injection (Chi Zhang and Gary Ruvkun, personal communications) and certain 
RNAi triggers introduced by feeding (e.g. unc-22) can partially bypass the requirement for RDE-
10 and RDE-11.  It is plausible that enhancement of RDE-1 association with target mRNAs, 
either through unusually strong primary siRNA-mRNA base-pairing or by high concentration of 
primary siRNAs, is sufficient for recruitment of RRF-1 to target mRNAs.   
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How does the RDE-10/RDE-11 complex promote secondary siRNA synthesis? RRF-1 
may be recruited to the target mRNAs through protein-protein interactions.  Such interactions 
may be transient since we did not detect RRF-1 in our proteomic analysis of RDE-10 associated 
proteins.  We also consider an alternative scenario.   At the initial phase of exogenous RNAi, a 
fine balance must be maintained between degradation and retention of target mRNAs.  This is 
because if target mRNAs are degraded too rapidly, no template will be available for RRF-1 to 
synthesize secondary siRNAs.  The RDE-10/RDE-11 complex preferentially associates with the 
region 5’ to the RNAi trigger, in target mRNAs that are 5’ capped (Fig. 2.7F) but lack a poly(A) 
tail (Fig.2.7D and Fig. 2.10 ).  We therefore hypothesize that the RDE-10/RDE-11 complex 
generates and stabilizes partially degraded target mRNAs, which facilitates RRF-1 recruitment 
and/or its synthesis of secondary siRNAs.     
  Our deep sequencing analysis of small RNAs indicates that RDE-10 and RDE-11 are 
required for secondary siRNA synthesis, which is crucial for exogenous RNAi.  In contrast, 
RDE-10 and RDE-11 are dispensable for the synthesis of selected endogenous siRNAs and 
micro-RNAs (Fig. 2.8D and E).  This is in agreement with a more comprehensive survey of 
endogenous small RNAs in rde-10 and rde-11 mutant animals, which reveals the depletion of a 
small subset of endogenous siRNAs (Chi Zhang and Gary Ruvkun, personal communications).   
It is conceivable that the synthesis of endogenous secondary siRNAs is promoted by functional 
paralogs of RDE-10 and RDE-11 in C. elegans.     
The specificity of the RNAi pathway is dictated by base pairing between target mRNAs 
and siRNA bound by Argonaute proteins.  Both RDE-10 and RDE-11 can be recruited to target 
mRNA specifically.  However, we did not detect any Argonaute family members in the 
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exogenous RNAi pathway as RDE-10 interacting proteins in our proteomic analysis.  One 
possible reason is that the interaction between RDE-10 and Argonautes is too transient to be 
captured under our immunoprecipitation conditions. Or this could suggest a “drop off” model: 
once recognized by an Argonaute-containing complex, target mRNAs are labeled and then 
dropped off at a subcellular compartment where RDE-10/RDE-11 dependent degradation takes 
place. The “label” could be a protein (e.g. RSD-2 or RDE-10) or modifications of target mRNAs 
at their 5’ or 3’ end. 
Although multiple models exist in other organisms, it is currently unknown if target 
mRNA degradation by RNAi in C. elegans is initiated by deadenylation, which is followed by 3’ 
→ 5’ degradation by the exosome and/or 5’ → 3’ degradation  initiated by de-capping. 
Alternatively, endonucleolytic cleavage within the target mRNA could be the initial step of 
degradation. We found that RDE-10 associated target mRNAs retained a 5’ cap structure (Fig. 
2.7F).  Therefore, it was unlikely that the RDE-10/RDE-11 complex would promote de-capping. 
It is plausible that RDE-11 could instigate target mRNA degradation through recruitment of 
additional factors.  Although a handful of conserved RISC components have been identified in C. 
elegans, they have only been reported to act in microRNA mediated gene silencing but not in 
RNAi (Caudy et al. 2003).  Therefore, the RDE-10/RDE-11 complex may operate in conjunction 
of RISC in C. elegans.  This is compatible with a previously proposed two-step model for RNAi 
in C. elegans (Yigit et al. 2006). The pioneering rounds of target mRNA degradation can be 
carried out by primary siRNA directed RDE-10/RDE-11 complex (Fig. 2.12), which is followed 
by full gene silencing by secondary siRNA directed RISC complex and nuclear RNAi apparatus.  
Nevertheless, we cannot rule out the possibility that the RDE-10/RDE-11 complex is required in 
additional gene silencing mechanisms subsequent to secondary siRNA synthesis (Fig. 2.12).  
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In C. elegans and plants, amplification of small RNAs is critical for potent endogenous 
and exogenous RNAi response and anti-viral immunity (Chapman and Carrington 2007; Ding 
2010).  Although conserved proteins such as Argonautes and RNA-dependent RNA polymerases 
are clearly involved, the precise mechanism of amplification differs.  We propose that the 
divergence of the exogenous RNAi pathway in C. elegans can in part be attributed to its 
dependence on the RDE-10/RDE-11 complex.  Further analysis of the C. elegans RNAi 
pathways should yield insights into how small RNA based regulation of gene expression can 
drift through evolution and provide clues on how to improve the efficiency of RNAi in 
heterologous systems.   
RDE-12 is predicted to be an ATP-dependent DEAD-box RNA helicase. We showed 
here that GFP::RDE-12 was localized to P granules. P granules are considered as multifunctional 
compartments rather than single function compartments. Diverse proteins are enriched in P 
granules such as components of the spliceosome (Sm proteins); components of the RNAi 
pathway (CSR-1, DRH-3); PGL-1, a protein that binds an isoform of the mRNA cap-binding 
protein eIF4E (Sheth et al. 2010). So the localization of RDE-12 suggests that RDE-12 is likely 
to be involved in RNA metabolism. Indeed, we found that RDE-12 is required for RNAi and 
engages target mRNAs in response to RNAi. Our results successfully proved the connection 
between RDE-12’s function and its subcellular localization.   
DEAD-box RNA helicases are found to catalyze different biochemical activities: RNA 
duplex unwinding, protein displacement from RNA and strand annealing. So it is hard to predict 
the exact function of RDE-12 based on its homology to other RNA helicases (Jankowsky and 
Fairman 2007). However, RNA helicases are generally thought to function in the context of 
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larger RNP complexes, where the helicases interact with other cellular proteins. Therefore, to 
define the function of RDE-12, it is crucial for us to find out what RNA molecules and proteins 
are interacting with RDE-12. We showed that RDE-12 engages target mRNAs. It will be 
interesting to know which part of the target mRNAs RDE-12 binds. Does RDE-12 bind 5’ Cap, 3’ 
UTR, upstream of siRNA matching site or downstream of siRNA matching site? Does RDE-12 
bind consensus sequence of target mRNAs? To answer these questions, CLIP (in vivo Cross-
Linking and Immuno-Precipitation) would be the ideal approach. This method is designed for 
identifying protein-RNA direct interaction sites in living cell (Ule et al. 2005). In this approach, 
proteins and RNAs with direct interaction are cross-linked by UV irradiation. Most regions of 
RNAs, except those bound by proteins, will be degraded after RNase treatment. Those protected 
small pieces of RNAs will be reverse transcribed to cDNAs. Then cDNAs will be directly 
sequenced with the Next Generation Sequencing technology.  
To identify RDE-12 interacting proteins, we could perform large scale immuno-
precipitations followed by MudPIT proteomics approach. We have successfully identified RDE-
11 and RDE-12 as members of the RDE-10 complex, so we expect that this experiment will 
identify novel components residing in RDE-12 associated foci. The helicase core can be divided 
into two sub-domains: domain 1 and domain 2. Recent study showed that domain 1 acts as an 
ATP-binding domain and domain 2 acts as an RNA binding domain (Mallam et al. 2012). By 
introducing mutation into different motifs in two domains, we will be able to disrupt the function 
of one domain but not the other. We will also be able to disrupt the helicase activity only but not 
the ATP-binding and RNA-binding activity. Our goal is to define the molecular determinants in 
the RDE-12 protein that are necessary for RNAi, and establish a link between RDE-12 
localization and function. 
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mRNAs targeted by RNAi are considered to be sorted into P bodies (Liu et al. 2005; 
Eulalio et al. 2007). In this work, we showed RDE-12 binds target mRNAs and forms a distinct 
cytoplasmic foci other than P bodies. This intriguing finding suggests that target mRNAs may 
not be sorted into P bodies for degradation immediately in C. elegans. This makes intuitive sense, 
as target mRNAs are the templates of secondary siRNA synthesis. It will not be beneficial for the 
amplification of RNAi response that target mRNAs are degraded immediately. This is further 
supported by the siRNA deep sequencing that rde-12(-) mutants are defective in secondary 
siRNA biogenesis.  mRNAs that recognized by RISC are believed to either undergoing 
immediate degradation or progressive depolyadenylation, which can be called the “on-site” 
model.  The findings in this work could suggest a “drop off” model in C. elegans: once 
recognized by an Argonaute-containing complex, target mRNAs are labeled and then dropped 
off at a subcellular compartment where RDE-10/RDE-11 dependent degradation takes place. The 
“label” could be RDE-12! Identifying physical interaction between RDE-12 and Argonaute 
proteins will further support this idea.  RDE-12 could act as the link between mRNAs targeting 
and secondary siRNA amplification in RNAi pathway in C. elegans.  
It is becoming more and more apparent that the fundamental mechanism underlying 
various small RNA pathways is essential for our understanding of the gene expression regulation 
and genome stability in disease pathogenesis and essentially animal development. Since RNA 
mediated gene silencing shows great potential in gene therapy, the basic mechanisms of RNAi 
have been adapted to apply in clinical treatment. As regulatory small RNA pathways are 
intertwined, it is extremely important to discover what the difference among small RNA 
pathways is, so that we can employ one without hampering others. The work described here 
studied the fundamental mechanisms of RNAi pathway in nematode C. elegans. Considering the 
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similarity among small RNA pathways in different organism, these findings will provide insights 
on understanding small regulatory RNA pathways outside of nematode Caenorhabditis elegans.  
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